Abstract
Two novel ligands for cerebral cannabinoid receptor (CB1), 1-(2,4-dichlorophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl) -1H-pyrazole-3-carboxamide (JHU75528) and 1-(2-bromophenyl)-4-cyano-5-(4- methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (JHU75575) have been synthesized. Both JHU75528 and JHU75575 display a combination of higher binding affinity and lower lipophilicity than those of Rimonabant (SR141716), a high affinity CB1 selective antagonist, and AM281, the only available ligand for emission tomography imaging of CB1 in human subjects. Radiolabeled [ 11C]JHU75528 and [11C]JHU75575 were prepared by reaction of [11C]methyl iodide with nor-methyl precursors. The average radiochemical yield, specific radioactivity, and radiochemical purity of [ 11C]JHU75528 were 16%, 235 GBq/μmol (6360 mCi/μmol), and 99%, respectively; those of [11C]JHU75575 were 8%, 196 GBq/μmol (5308 mCi/μmol), and 99%, respectively. Both ligands hold promise as PET radioligands for imaging CB1 receptor.
Original language | English (US) |
---|---|
Pages (from-to) | 1021-1036 |
Number of pages | 16 |
Journal | Journal of Labelled Compounds and Radiopharmaceuticals |
Volume | 49 |
Issue number | 12 |
DOIs | |
State | Published - Oct 30 2006 |
Keywords
- Cannabinoid receptor
- Carbon-11
- Positron emission tomography
- Rimonabant
- SR141716
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry
- Radiology Nuclear Medicine and imaging
- Drug Discovery
- Spectroscopy
- Organic Chemistry